Human Technopole: a new building for scientific research
Milan, 3 April 2020 – Ten floors high, over 16.500 square meters exclusively dedicated to research laboratories and 3.000 square meters of terraces and green areas: a snapshot of the project for the new Human Technopole building, Italy’s research institute for life sciences based at the heart of MIND Milano Innovation District. The building which aims to be modern as well as welcoming, will be the main headquarters of scientific laboratories and the centre of Human Technopole’s campus.
The name of the designer who won the international competition for the design of the building and the campus was announced today by Human Technopole Foundation and Arexpo: the winner is Piuarch, a firm based in Milan which has contributed to many major redevelopment projects in the city, including the Mecenate District and the area of Porta Nuova.
An investment of up to 94.5 million euros is planned for the construction of the new building.
The Human Technopole Campus includes three existing buildings, Palazzo Italia the iconic Milan EXPO 2015 pavilion, a North Pavilion and a South Pavilion and will cover an overall area of over 11.000 square meters. The project describes how the different buildings will be interconnected as well as how connections with external areas will be developed.
The new building will rise within the area of the campus and is expected to be built in 1.100 consecutive days, equivalent to about three years. It will have an overall surface of 35.000 square meters and at its highest point will be 61 meters high. It will host biochemistry and molecular biology laboratories, cutting edge scientific technology including light microscopy, space for an extension of HT’s Cryo-EM facility as well as 800 workstations for researchers. In addition, large common areas, meeting rooms and classrooms for events and trainings will be available.
Read the full press release here.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.